26 May 2026

strategyland.uk

British American Tobacco P.l.c (BATS)

Rank #75 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

British American Tobacco P.l.c

BATS.L·Consumer Non-Cyclicals·Market Cap £105.8b

Rank #75 of 100

Data from Excel Model · 100 Stocks Analysed

£48.50

+16.09% YTD

Target: £49.83(+2.7%)

52W: £32.65 - £53.26

Score Analysis

British American Tobacco P.l.c is ranked #75 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

51/100

Average Score

Liquidity

Weak63/100

Valuation

Fair57/100

Profitability

Weak78/100

Solvency

Good34/100

Asset Efficiency

Weak100/100

Mkt Trading

Excellent5/100

Technical

Excellent19/100

1. Valuation

Score: 57/100

Is BATS undervalued compared to its peers and fair value metrics?

1/5

valuation criteria met

✗

FY26e P/E Ratio

13.6xRank 46/100

✗

FY27e P/E Ratio

12.6xRank 44/100

✓

Price-to-Book

2.00xRank 40/100

✗

Price-to-Tangible Book

N/ARank 101/100

✗

EV/EBITDA

10.0xRank 47/100

Key Valuation Metrics

Current P/E

13.9x

Price-to-Earnings

FY26e P/E

13.6x

Forward estimate

FY27e P/E

12.6x

Forward estimate

P/B Ratio

2.00x

Price-to-Book

P/TBV

N/A

Price-to-Tangible Book

EV/EBITDA

10.0x

Enterprise Value

FY26e EV/EBITDA

10.6x

Forward estimate

FY27e EV/EBITDA

10.6x

Forward estimate

Analyst Consensus Target

Current Price

£48.50

Consensus Target

£49.83

Potential

+2.7%

Target

Bloomberg Median Target: £51.50

2. Profitability

Score: 78/100

How profitable is BATS relative to its peers?

0/6

profitability criteria met

✗

TTM Profit Margin

30.3%Rank 78/100

–

Current ROE

16.5%

–

Current ROA

N/A

✗

FY26e EPS

3.89Rank 82/100

–

TTM EPS

3.73

–

Net Income Growth

N/A

Profit Margin

30.3%

ROE

16.5%

FY27e ROE

17.9%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 34/100

How strong is BATS's balance sheet and financial position?

1/4

solvency criteria met

–

Debt-to-Equity

71.7%

–

Interest Coverage

N/A

✓

Debt/EBITDA

Rank 30Rank 30/100

–

Altman Z-Score

2.09

Key Health Metrics

Quick Ratio

0.57

Below 1.0

Cash Ratio

0.87

Debt/Equity

72%

FCF Margin

1.9%

Altman Z-Score

2.09

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 100/100

How efficiently does BATS deploy its assets and intellectual capital?

1/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

✓

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

Rank 20/100

Overall Asset Efficiency Rank

Rank within sector peers#100/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.